Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children

Area of Science:

• Pediatrics
• Microbiology
• Public Health

Background:

• Streptococcus pneumoniae colonization is a major global health concern, particularly in young children.
• Antibiotic resistance in pneumococcal isolates poses a significant threat to effective treatment and prevention strategies.
• Understanding colonization patterns and resistance is crucial for vaccine development and public health interventions in low-resource settings.

Purpose of the Study:

• To determine the prevalence and characteristics of pneumococcal colonization in children under five years old in rural Malawi.
• To assess the antimicrobial susceptibility patterns of pneumococcal isolates.
• To identify risk factors associated with antibiotic resistance and evaluate the coverage of existing pneumococcal vaccines.

Main Methods:

• Nasopharyngeal swabs were collected from 906 Malawian children under five years old attending rural health clinics.
• Pneumococcal colonization was identified, and isolates were tested for susceptibility to trimethoprim-sulfamethoxazole and penicillin.
• Data on recent antibiotic use and serotype distribution were analyzed in relation to colonization and resistance.

Main Results:

• High rates of pneumococcal colonization (84%) were observed, with early onset (65% in children <3 months old).
• A significant proportion of isolates exhibited nonsusceptibility to trimethoprim-sulfamethoxazole (46%) and penicillin (21%).
• Previous month's trimethoprim-sulfamethoxazole use was a risk factor for both trimethoprim-sulfamethoxazole and penicillin nonsusceptibility. Forty-three percent of isolates were covered by the 7-valent pneumococcal conjugate vaccine, with 37% being vaccine-related serotypes (e.g., 6A, 19A).

Conclusions:

• Pneumococcal colonization is highly prevalent and occurs early in young Malawian children.
• Antimicrobial resistance, particularly to trimethoprim-sulfamethoxazole and penicillin, is a considerable issue, linked to prior antibiotic exposure.
• While current vaccines cover a portion of circulating serotypes, a substantial number of vaccine-related serotypes, including those associated with resistance, warrant further investigation and potential inclusion in future vaccine formulations.